跳至主要内容
临床试验/NCT03493204
NCT03493204已完成不适用

Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial

University of Michigan2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2018年4月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
2
主要终点
Number of therapeutic paracenteses

研究概览

简要总结

The purpose of this study is to determine the feasibility of a home meal delivery program for patients with cirrhosis and ascites and to determine the effectiveness of a salt-restricted (2 gram sodium) meal delivery program in reducing the need for therapeutic paracenteses and/or all-cause re-admissions for these patients. Many patients with cirrhosis don't have enough nutrients in the body and are frail and these meals may help them maintain a good diet and lead to improved quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult 18 years or older of age
  • Clinical diagnosis of cirrhosis with ascites. Diagnosis of cirrhosis will be based upon:
  • liver biopsy, OR
  • history of cirrhosis complication: ascites, variceal bleeding, hepatic encephalopathy, OR
  • 2 of the following 4 criteria: i. Ultrasound (US), computerized axial tomography (CT) or Magnetic Resonance Imaging (MRI) imaging findings of cirrhosis (cirrhotic appearing liver, splenomegaly, varices, ascites) ii. Fibroscan liver stiffness score >13 kPa iii. Laboratory testing: Aspartate Aminotransferase (AST)/platelet ratio index (APRI) >2.0 iv. CT, MRI or Esophagogastroduodenoscopy (EGD) showing presence of esophageal varices
  • At least one of the following: Any cause hospitalization within 90 days OR outpatient therapeutic paracentesis within 30 days

排除标准

  • Language barriers that cannot be surmounted with in-person interpreters
  • Estimated life expectancy < 3 months
  • Pregnancy (self-reported)
  • Unable or unwilling to provide consent
  • History of liver transplant
  • Planned discharge to nursing facility
  • Anuria or serum creatinine > 2.0 mg/dL
  • Uncontrolled hepatic encephalopathy

研究组 & 干预措施

Home-delivered, salt restricted

Experimental

Meal description: salt-restricted (1500 mg to 2000 mg daily), > 2100 kilocalorie, high protein (>80 g daily) in addition to receiving standard pamphlet receipt

干预措施: Meal delivery (Other)

Dietary Advice

Active Comparator

Standard of care, advice on salt-restriction using standard pamphlet receipt

干预措施: Standard pamphlet with Dietary Advice (Other)

结局指标

主要结局

Number of therapeutic paracenteses

时间窗: From date of randomization until 12 weeks

Number of paracenteses

次要结局

  • Change in Quality of life(baseline, week 12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elliot B. Tapper

Assistant Professor of Internal Medicine

University of Michigan

研究点 (2)

Loading locations...

相似试验